Ready to close the gap in HER2-mutant NSCLC care? Join Memorial Sloan Kettering experts Helena A. Yu, MD, and Maria Arcila, MD, for a live webinar on optimizing HER2 testing and integrating the latest targeted therapies into your practice. They’ll walk through how to improve detection and ensure your patients are getting the most effective, up-to-date treatments available.
You can catch the live session on either of these dates:
Wednesday, January 8 at 5:00 pm ET: https://bit.ly/4iZxnA0
Monday, January 26 at 5:00 pm ET: https://bit.ly/4qALw9J
All content for Oncology Data Advisor is the property of i3 Health and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Ready to close the gap in HER2-mutant NSCLC care? Join Memorial Sloan Kettering experts Helena A. Yu, MD, and Maria Arcila, MD, for a live webinar on optimizing HER2 testing and integrating the latest targeted therapies into your practice. They’ll walk through how to improve detection and ensure your patients are getting the most effective, up-to-date treatments available.
You can catch the live session on either of these dates:
Wednesday, January 8 at 5:00 pm ET: https://bit.ly/4iZxnA0
Monday, January 26 at 5:00 pm ET: https://bit.ly/4qALw9J
Improving Early and Equitable Lung Cancer Detection With Sybil: Mary Pasquinelli, DNP, FNP-BC, CTTS, and Waqas Haque
Oncology Data Advisor
18 minutes 41 seconds
2 months ago
Improving Early and Equitable Lung Cancer Detection With Sybil: Mary Pasquinelli, DNP, FNP-BC, CTTS, and Waqas Haque
Click here to view the full article on Oncology Data Advisor: https://oncdata.com/mary-pasquinelli-sybil-ai
In this episode of Exploring AI in Oncology, Dr. Waqas Haque speaks with Mary Pasquinelli, DNP, Nurse Practitioner and Director of the Lung Screening Program at the University of Illinois (UI) Health, about the evolving role of screening and artificial intelligence (AI) in lung cancer detection. Their conversation spans program design, health equity, AI validation in diverse populations, multimodal detection with circulating tumor DNA (ctDNA) and imaging, and practical strategies that boost adherence and impact in both academic and community settings.
Oncology Data Advisor
Ready to close the gap in HER2-mutant NSCLC care? Join Memorial Sloan Kettering experts Helena A. Yu, MD, and Maria Arcila, MD, for a live webinar on optimizing HER2 testing and integrating the latest targeted therapies into your practice. They’ll walk through how to improve detection and ensure your patients are getting the most effective, up-to-date treatments available.
You can catch the live session on either of these dates:
Wednesday, January 8 at 5:00 pm ET: https://bit.ly/4iZxnA0
Monday, January 26 at 5:00 pm ET: https://bit.ly/4qALw9J
